Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001085146-21-001052
Filing Date
2021-02-25
Accepted
2021-02-25 15:50:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 COWEN FINANCIAL PRODUCTS LLC cldx_22521.htm SC 13G 25704
  Complete submission text file 0001085146-21-001052.txt   27384
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 21680022
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 599 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE NEW YORK NY 10022 6465621000
Cowen Financial Products LLC (Filed by) CIK: 0001771015 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G